View Item 

Show simple item record

THE CORRELATION BETWEEN ANIMAL TESTING PROCEDURES AND CLINICAL EFFECTIVENESS OF CENTRALLY ACTING MUSCLE RELAXANTS OF THE MEPHENESIN TYPE
dc.contributor.authorDomino, Edward F.en_US
dc.date.accessioned2010-06-01T18:35:57Z
dc.date.available2010-06-01T18:35:57Z
dc.date.issued1956-11en_US
dc.identifier.citationDomino, Edward F. (1956). "THE CORRELATION BETWEEN ANIMAL TESTING PROCEDURES AND CLINICAL EFFECTIVENESS OF CENTRALLY ACTING MUSCLE RELAXANTS OF THE MEPHENESIN TYPE." Annals of the New York Academy of Sciences 64(4 Experimental Methods for the Evaluation of Drugs in Various Disease States ): 705-729. <http://hdl.handle.net/2027.42/71801>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71801
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=13373239&dopt=citationen_US
dc.format.extent1624428 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1956 The New York Academy of Sciencesen_US
dc.titleTHE CORRELATION BETWEEN ANIMAL TESTING PROCEDURES AND CLINICAL EFFECTIVENESS OF CENTRALLY ACTING MUSCLE RELAXANTS OF THE MEPHENESIN TYPEen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, Mich.en_US
dc.identifier.pmid13373239en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71801/1/j.1749-6632.1956.tb36842.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1956.tb36842.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceAbrahamsen, E. H. & H. W. Baird. 1956. The use of zoxazolamine (Flexin) in children with cerebral palsy—preliminary report. J. Am. Med. Assoc. 160: 749 – 751.en_US
dc.identifier.citedreferenceAbreu, B. E., A. B. Richards, L. C. Weaver, G. R. Burch, C. A. Bunde, E. R. Bockstahler & D. L. Wright. 1955. Pharmacologic properties of 4-alkoxy-Β-(1-piperidyl) propiophenones. J. Pharmacol. Exptl. Therap. 116: 419 – 426.en_US
dc.identifier.citedreferenceAmols, W. 1955. Personal communication.en_US
dc.identifier.citedreferenceAmols, W. 1956. Clinical experience with a new muscle relaxant, zoxazolamine—preliminary report. J. Am. Med. Assoc. 160: 742 – 745.en_US
dc.identifier.citedreferenceArduini, A. & M. G. Arduini. 1954. Effect of drugs and metabolic alterations on brain stem arousal mechanism. J. Pharmacol. Exptl. Therap. 110: 76 – 85.en_US
dc.identifier.citedreferenceAriens Kappers, C. U., G. C. Huber & E. C. Crosby. 1936. The Comparative Anatomy of the Nervous System of Vertebrates, Including Man. I, II. Macmillan. New York, N.Y.en_US
dc.identifier.citedreferenceBasmajian, J. V. & A. Szatmari. 1955. Chlorpromazine and human spasticity: An electromyographic study. Neurology. 5: 856 – 860.en_US
dc.identifier.citedreferenceBerger, F. M. 1947. Mode of action of Myanesin. Brit. J. Pharmacol. 2: 241 – 250.en_US
dc.identifier.citedreferenceBerger, F. M. 1949a. Spinal cord depressant drugs. Pharmacol. Rev. 1: 243 – 278.en_US
dc.identifier.citedreferenceBerger, F. M. 1949b. The pharmacological properties of 2-methyl, 2-n-amyl-4-hydroxy-methyl-1,3-dioxolane (Glyketal), a new blocking agent of interneurons. J. Pharmacol. Exptl. Therap. 96: 213 – 223.en_US
dc.identifier.citedreferenceBerger, F. M. 1954. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (Miltown), a new interneuronal blocking agent. J. Pharmacol. Exptl. Therap. 112: 413 – 423.en_US
dc.identifier.citedreferenceBerger, F. M. 1955a. Miltown, a long-acting mephenesinlike drug. Federation Proc. 14: 318 – 319.en_US
dc.identifier.citedreferenceBerger, F. M. 1955b. Personal communication.en_US
dc.identifier.citedreferenceBerger, F. M., V. Boekelheide & D. S. Tarbell. 1948. The pharmacological properties of some 2-substituted-4-hydroxymethyl-1,3-dioxolanes. Science. 108: 561 – 562.en_US
dc.identifier.citedreferenceBerger, F. M. & W. Bradley. 1946. The pharmacological properties of Α:Β dihydroxy-Γ-(2-methylphenoxy)-propane (Myanesin). Brit. J. Pharmacol. 1: 265 – 272.en_US
dc.identifier.citedreferenceBerger, F. M. & B. J. Ludwig. 1950. The anticonvulsant action of 2,2-diethyl 1,3-pro-panediol (DEP) and some of its homologues and esters. J. Pharmacol. Exptl. Therap. 100: 27 – 37.en_US
dc.identifier.citedreferenceBerger, F. M. & R. P. Schwartz. 1948. Oral “Myanesin” in treatment of spastic and hyperkinetic disorders. J. Am. Med. Assoc. 137: 772 – 774.en_US
dc.identifier.citedreferenceBernhard, C. G., & E. Bohm. 1954. Cortical representation and functional significance of the corticomotoneuronal system. Am. Med. Assoc. Arch. Neurol. Psychiat. 72: 473 – 502.en_US
dc.identifier.citedreferenceBernhard, C. G., E. Bohm & I. Petersen. 1953. Investigations on the organization of the corticospinal system in monkeys (Macaca mulatta). Acta Physiol. Scand. Suppl. 106: 79 – 105.en_US
dc.identifier.citedreferenceBiehl, J. P. & R. A. Helm. 1951. The use of mephenesin in controlling the spasms of tetanus. J. Lab. Clin. Med. 38: 791.en_US
dc.identifier.citedreferenceBoles, T. C. & J. H. Smith. 1951. Mephenesin in treatment of tetanus: Results of oral administration in three cases. J. Am. Med. Assoc. 146: 1296 – 1298.en_US
dc.identifier.citedreferenceBonnett, R., J. R. Cannon, A. W. Johnson, I. Sutherland, A. R. Todd & E. L. Smith. 1955. The structure of vitamin B 12 and its hexacarboxylic acid degradation product. Nature. 176: 328 – 330.en_US
dc.identifier.citedreferenceBorrus, J. C. 1955. Study of effect of Miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states. J. Am. Med. Assoc. 157: 1596 – 1598.en_US
dc.identifier.citedreferenceChen, G., J. W. Kissel & E. F. Domino. 1956. The central depressant actions of ethyl trichloramate [ethyl(2,2,2-trichloro-1-hydroxyethyl carbamate)]. Federation Proc. 15: 408.en_US
dc.identifier.citedreferenceClark, G. 1952. The pyramidal tract. Chicago Med. School Quart. 13: 156 – 162.en_US
dc.identifier.citedreferenceCook, L. & D. D. Bonnycastle. 1953. An examination of some spinal and ganglionic actions of analgetic materials. J. Pharmacol. Exptl. Therap. 109: 35 – 44.en_US
dc.identifier.citedreferenceDavis, H., C. H. Hine, M. W. Neal, H. E. Christensen & F. J. Murphy. 1952. Some pharmacologic comparisons of 1-ethoxy, 3-isopropoxypropane-2-ol and 3-(2′methylphenoxy) propane-1,2-diol (Myanesin). Arch, intern, pharmacodynamie. 89: 145 – 159.en_US
dc.identifier.citedreferenceDe Bodo, R. C. & C. Mc Brooks. 1937. The effects of morphine on blood sugar and reflex activity in the chronic spinal cat. J. Pharmacol. Exptl. Therap. 61: 82 – 88.en_US
dc.identifier.citedreferenceDelapresnaye, J. F., E. D. Adrian, F. Bremer & H. H. Jasper. 1954. Brain Mechanisms and Consciousness, a Symposium. Blackwell Scientific Publications, Ltd. Oxford & C.C. Thomas. Springfield, Ill.en_US
dc.identifier.citedreferenceDenhoff, E., V. N. Smirnoff & R. H. Holden. 1951. Cerebral palsy. New Engl. J. Med. 245: 770 – 777.en_US
dc.identifier.citedreferenceDenny-Brown, D. 1950. Disintegration of motor function resulting from cerebral lesions. J. Nervous Mental Disease. 112: 1 – 45.en_US
dc.identifier.citedreferenceDietrich, W. C. 1955. Personal communication.en_US
dc.identifier.citedreferenceDixon, H. H., H. A. Dickel, R. A. Coen & G. B. Haugen. 1950. Clinical observations on Tolserol in handling anxiety tension states. Am. J. Med. Sci. 220: 23 – 29.en_US
dc.identifier.citedreferenceDomino, E. F. 1951. Spinal interneuron depression by benzazoles. Master's thesis. Dept. Pharmacol. Univ. Ill. Chicago, Ill.en_US
dc.identifier.citedreferenceDomino, E. F. 1955. A pharmacological analysis of the functional relationship between the brain stem arousal and diffuse thalamic projection systems. J. Pharmacol. Exptl. Therap. 115: 449 – 463.en_US
dc.identifier.citedreferenceDomino, E. F. 1956a. Further observations on the CNS actions of a convulsant barbiturate compared with pentobarbital. J. Pharmacol. Exptl. Therap. 116: 17.en_US
dc.identifier.citedreferenceDomino, E. F. 1956b. Electrical activity of partially neuronally isolated cat cerebral cortex. Electroencephalog. and Clin. Neurophysiol.: 341 – 342.en_US
dc.identifier.citedreferenceDomino, E. F. 1956c. Unpublished observations.en_US
dc.identifier.citedreferenceDomino, E. F., K. E. Fox & T. M. Brody. 1955. Pharmacological actions of a convulsant barbiturate [sodium 5-ethyl-5-(1,3-dimethylbutyl) barbiturate]. I. Stimulant and depressant effects. J. Pharmacol. Exptl. Therap. 114: 473 – 483.en_US
dc.identifier.citedreferenceDomino, E., R. J. Petersen & K. R. Unna. 1951. The anticonvulsant properties of some benzazoles. J. Pharmacol. Exptl. Therap. 103: 342.en_US
dc.identifier.citedreferenceDomino, E. F., K. R. Unna & J. Kerwin. 1952. Pharmacological properties of benzazoles. I. Relationship between structure and paralyzing action. J. Pharmacol. Exptl. Therap. 105: 486 – 497.en_US
dc.identifier.citedreferenceDrew, A. L. 1955. Personal communication.en_US
dc.identifier.citedreferenceEccles, J. C., P. Fatt & S. Landgren. 1956. Central pathway for direct inhibitory action of impulses in largest afferent nerve fibres to muscle. J. Neurophysiol. 19: 75 – 98.en_US
dc.identifier.citedreferenceEffron, A. S. & W. M. Schultz. 1951. An evaluation of Artane and Tolserol in the treatment of spastic disorders. Am. J. Med. Sci. 221: 561 – 566.en_US
dc.identifier.citedreferenceErspamer, V. 1954. Pharmacology of indolealkylamines. Pharmacol. Rev. 6: 425 – 487.en_US
dc.identifier.citedreferenceFinkelman, I. & N. B. Dobin. 1949. Effect of Α,Β-dihydroxy-Γ-(2-methylphenoxy) propane (Lissephen) on excitation of motor cortex and conduction through the pyramids. J. Nervous Mental Disease. 109: 323 – 325.en_US
dc.identifier.citedreferenceFrench, J. D., M. Verzeano & H. W. Magoun. 1953. Neural basis of anesthetic state. Am. Med. Assoc. Arch. Neurol. Psychiat. 69: 519 – 529.en_US
dc.identifier.citedreferenceFriend, D. B. 1955. Personal communication.en_US
dc.identifier.citedreferenceFulton, J. F. 1937. Spasticity and the frontal lobes. A review. New Engl. J. Med. 217: 1017 – 1024.en_US
dc.identifier.citedreferenceFulton, J. F. 1949. Physiology of the Nervous System. Oxford Univ. Press. New York, N. Y.en_US
dc.identifier.citedreferenceFulton, J. F. & M. A. Kennard. 1934. A study of flaccid and spastic paralyses produced by lesions of the cerebral cortex in primates. Research Nervous Mental Disease Proc. 13: 158 – 210.en_US
dc.identifier.citedreferenceFunderburk, W. H., E. E. King & K. R. Unna. 1951. The site of action of benzazoles in the central nervous system. J. Pharmacol. Exptl. Therap. 103: 343 – 344.en_US
dc.identifier.citedreferenceFunderburk, W. H., E. E. King, E. F. Domino & K. R. Unna. 1953a. Pharmacological properties of benzazoles. II. Sites of action in the central nervous system. J. Pharmacol. Exptl. Therap. 107: 356 – 367.en_US
dc.identifier.citedreferenceFunderburk, W. H., E. E. King & K. R. Unna. 1953b. Pharmacological properties of benzazoles. III. Effect of 2-aminobenzothiazoles on the electroencephalogram. J. Pharmacol. Exptl. Therap. 108: 94 – 103.en_US
dc.identifier.citedreferenceFunderburk, W. H. & K. R. Unna. 1953. Site of action of 2,2-diethyl 1,3-propanediol (Prenderol) on the central nervous system. J. Pharmacol. Exptl. Therap. 107: 344 – 355.en_US
dc.identifier.citedreferenceFunderburk, W. H. & R. T. Woodcock. 1955. Effects of 2-amino-5-chlorobenzoxazole on the central nervous system. Federation Proc. 14: 341.en_US
dc.identifier.citedreferenceGarol, H. W. & P. C. Bucy. 1944. Suppression of motor response in man. Am. Med. Assoc. Arch. Neurol. Psychiat. 51: 528 – 532.en_US
dc.identifier.citedreferenceGernandt, B. E. & C. A. Thulin. 1955. Reciprocal effects upon spinal motoneurons from stimulation of bulbar recticular formation. J. Neurophysiol. 18: 113 – 129.en_US
dc.identifier.citedreferenceGinzel, K. H. & H. Tschabitscher. 1951. Die Muskelrelaxantien in der Therapie neurologischer BewegungsstÖrungen. Wien. Z. Nervenheilk. 3: 498 – 506.en_US
dc.identifier.citedreferenceGlaser, G. H. 1956. Personal communication.en_US
dc.identifier.citedreferenceGodman, H. E. 1951. Mephenesin as a relaxing agent in the treatment of tetanus: Clinical experience in 12 cases. Calif. Med. 74: 126 – 127.en_US
dc.identifier.citedreferenceGoldman, M. A. & R. S. Snider. 1955. Mono- and multisynaptic arcs of cerebellum. J. Neurophysiol. 18: 536 – 546.en_US
dc.identifier.citedreferenceGomez, M. R., A. V. Rodriguez & A. L. Drew. 1956. Effect of zoxazolamine (Flexin) in treatment of spasticity—preliminary report. J. Am. Med. Assoc. 160: 752 – 754.en_US
dc.identifier.citedreferenceGoodman, L. 1943. The pharmacodynamic actions of benzimidazole: A preliminary report. Bull. New Engl. Med. Center. 5: 97 – 100.en_US
dc.identifier.citedreferenceGoodman, L. S. 1955. Personal communication.en_US
dc.identifier.citedreferenceGoodman, L., A. Gilman & N. Hart. 1943. Preliminary investigations on the pharmacology of benzimidazole. Federation Proc. 2: 80.en_US
dc.identifier.citedreferenceGoodman, L. & N. Hart. 1944. Further studies on the central nervous system action of benzimidazole. Federation Proc. 3: 73.en_US
dc.identifier.citedreferenceGoodman, L. S., E. A. Swinyard & J. E. P. Toman. 1946. Further studies on the anti-convulsant properties of Tridione (3,5,5-trimethyloxazolidine-dione). Federation Proc. 5: 179 – 180.en_US
dc.identifier.citedreferenceGoodsell, J. S., J. E. P. Toman, G. M. Everett & R. K. Richards. 1954. A search for more effective muscle relaxants among the glycerol ethers and dioxolanes. J. Pharmacol. Exptl. Therap. 110: 251 – 259.en_US
dc.identifier.citedreferenceGranit, R. 1955. Receptors and Sensory Perception. Yale Univ. Press. New Haven, Conn.en_US
dc.identifier.citedreferenceGranit, R. & B. Holmgren. 1955. Two pathways from brain stem to gamma ventral horn cells. Acta Physiol. Scand. 35: 93 – 108.en_US
dc.identifier.citedreferenceGranit, R., B. Holmgren & P. A. Merton. 1955. The two routes for excitation of muscle and their subservience to the cerebellum. J. Physiol. 130: 213 – 224.en_US
dc.identifier.citedreferenceHagbarth, K. E. & K. Naess. 1950. Reflex effects of tetanic stimulation of different afferent fiber-systems in the hind limb of the cat. Acta Physiol. Scand. 21: 336 – 361.en_US
dc.identifier.citedreferenceVan Harreveld, A. 1947. Effect of ether and pentobarbital on the polarisation state of central nervous elements. Am. J. Physiol. 150: 541 – 550.en_US
dc.identifier.citedreferenceVan Harreveld, A. 1940. On spinal shock. Am. J. Physiol. 129: 515 – 523.en_US
dc.identifier.citedreferenceVan Harreveld, A. & G. A. Feigen. 1950. Effect of some drugs on the polarization state of spinal cord elements. Am. J. Physiol. 160: 451 – 461.en_US
dc.identifier.citedreferenceVAN Harreveld, A. & G. Marmont. 1939. The course of recovery of the spinal cord from asphyxia. J. Neurophysiol. 2: 101 – 111.en_US
dc.identifier.citedreferenceHendley, C. D., T. E. Lynes & F. M. Berger. 1954. Effect of 2-methyl,2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system. Proc. Soc. Exptl. Biol. Med. 87: 608 – 610.en_US
dc.identifier.citedreferenceHendley, C. D., T. E. Lynes & F. M. Berger. 1955. Effect of 2-methyl,2-n-propyl-1,3-propanediol dicarbamate (Miltown) on electrical activity of the brain. Federation Proc. 14: 351.en_US
dc.identifier.citedreferenceHenneman, E., A. Kaplan & K. R. Unna. 1949. A neuropharmacological study on the effect of Myanesin (Tolserol) on motor systems. J. Pharmacol. Exptl. Therap. 97: 331 – 341.en_US
dc.identifier.citedreferenceHenneman, E. & J. Scherrer. 1949. The effect of Α,Β-dihydroxy-Γ-(2 methylphenoxy) propane (Myanesin, Tolserol) on experimental spasticity in cats. J. Pharmacol. Exptl. Therap. 97: 342 – 348.en_US
dc.identifier.citedreferenceHerman, M. & A. S. Effron. 1951. Tolserol in the treatment of the postalcoholic state. Quart. J. Studies Ale. 12: 261 – 267.en_US
dc.identifier.citedreferenceHermann, I. F. & R. T. Smith. 1951. 3-o-Toloxy 1,2-propanediol in the treatment of rheumatic diseases. Lancet. 71: 271 – 274.en_US
dc.identifier.citedreferenceHine, C. H., H. E. Christensen, F. J. Murphy & H. Davis. 1949. The comparative muscle-paralyzing activity of some substituted glycerol ethers. J. Pharmacol. Exptl. Therap. 97: 414 – 419.en_US
dc.identifier.citedreferenceHines, M. 1936. The anterior border of the monkey's (Macaca mulatta) motor cortex and the production of spasticity. Am. J. Physiol. 116: 76.en_US
dc.identifier.citedreferenceHines, M. 1937. The “motor” cortex. Bull. Johns Hopkins Hosp. 60: 313 – 336.en_US
dc.identifier.citedreferenceHodes, R., S. M. Peacock, Jr. & R. G. Heath. 1951. Influence of the forebrain on somato-motor activity. I: Inhibition. J. Comp. Neurol. 94: 381 – 408.en_US
dc.identifier.citedreferenceHodes, R., S. M. Peacock, Jr. & R. G. Heath. 1954. Chapt. 4. Inhibition and facilitation of motor activity from forebrain stimulation in cats. Tulane University. Dept. of Psychiatry and Neurology. Studies in Schizophrenia. Harvard Univ. Press. Cambridge, Mass.en_US
dc.identifier.citedreferenceHodgkin, D. C., J. Pickworth, J. H. Robertson, K. N. Trueblood, R. J. Prosen & J. G. White. 1955. Structure of vitamin B 12. Nature. 176: 325 – 328.en_US
dc.identifier.citedreferenceHoff, E. C. 1932. Central nerve terminals in mammalian spinal cord and their examination by experimental degeneration. Proc. Roy. Soc. (B) 111: 175 – 188.en_US
dc.identifier.citedreferenceHoff, E. C. 1933. Interneuronal connections (boutons terminaux) of the human spinal cord. Am. J. Physiol. 106: 53 – 54.en_US
dc.identifier.citedreferenceHoff, E. C. & H. E. Hoff. 1934. Spinal terminations of the projection fibres from the motor cortex of primates. Brain. 57: 454 – 474.en_US
dc.identifier.citedreferenceJacqueline, F. 1950. Le cresoxy-propane-diol. Son employ per os en rhumatologie. Sem. HÔp. Paris. 26: 302 – 304.en_US
dc.identifier.citedreferenceKaada, B. R. 1950. Site of action of Myanesin (mephenesin, Tolserol) in the central nervous system. J. Neurophysiol. 13: 89 – 104.en_US
dc.identifier.citedreferenceKabat, H. & M. E. Knapp. 1944. The mechanism of muscle spasm in poliomyelitis. J. Pediat. 24: 123 – 137.en_US
dc.identifier.citedreferenceKamijo, K. & G. B. Koelle. 1955a. 2-amino-5-chlorobenzoxazole (McN-485), a long-acting spinal cord depressant. Federation Proc. 14: 356.en_US
dc.identifier.citedreferenceKamijo, K. & G. B. Koelle. 1955b. 2-amino-5-chlorobenzoxazole (McN-485, Flexin), a long-acting spinal cord depressant. Proc. Soc. Exptl. Biol. Med. 88: 565 – 568.en_US
dc.identifier.citedreferenceKing, E. E. 1953. Interneuronal depressant properties of atrolactamide. Federation Proc. 12: 336.en_US
dc.identifier.citedreferenceKing, E. E. 1954. Differential action of anesthetic and multineuronal blocking agents upon EEG arousal and recruitment responses evoked from the brain stem. Federation Proc. 13: 375.en_US
dc.identifier.citedreferenceKing, E. E. 1956. J. Pharmacol. Exptl. Therap. 116: 404 – 417.en_US
dc.identifier.citedreferenceKing, E. E., B. Minz & K. R. Unna. 1955. The effect of the brain stem reticular formation on the linguomandibular reflex. J. Comp. Neurol. 102: 565 – 596.en_US
dc.identifier.citedreferenceKing, E. E. & K. R. Unna. 1954. The action of mephenesin and other interneuron depressants on the brain stem. J. Pharmacol. Exptl. Therap. 111: 293 – 301.en_US
dc.identifier.citedreferenceKissel, J. & E. F. Domino. 1956. Unpublished observations.en_US
dc.identifier.citedreferenceKolmodin, G. M. 1953. The action of ethyl alcohol on the monosynaptic extensor reflex and the multisynaptic reflex. Acta Physiol. Scand. Suppl. 106: 530 – 537.en_US
dc.identifier.citedreferenceLang, D. A., K. K. Kimura & K. R. Unna. 1951. The combination of skeletal muscle relaxing agents with various central nervous system depressants used in anesthesia. Arch. Intern. pharmacodynamie. 85: 257 – 272.en_US
dc.identifier.citedreferenceLassek, A. M. 1954. The Pyramidal Tract: Its Status in Medicine. C. C Thomas. Springfield, Ill.en_US
dc.identifier.citedreferenceLatimer, C. N. 1955. Depression of transmission across single synapses by mephenesin. Federation Proc. 14: 91.en_US
dc.identifier.citedreferenceLettvin, J. Y. 1948. The path of suppression in the spinal grey matter. Federation Proc. 7: 71.en_US
dc.identifier.citedreferenceLevin, P. M. 1936. The efferent fibers of the frontal lobe of the monkey, Macaca, mulatta. J. Comp. Neurol. 63: 369 – 419.en_US
dc.identifier.citedreferenceLevin, P. M. & F. K. Bradford. 1938. The exact origin of the cortico-spinal tract in the monkey. J. Comp. Neurol. 68: 411 – 422.en_US
dc.identifier.citedreferenceLeyton, A. S. F. & C. S. Sherrington. 1917. Observations on the excitable cortex of the chimpanzee, orang-utan, and gorilla. Quart. J. Exptl. Physiol. 11: 135 – 222.en_US
dc.identifier.citedreferenceLibet, B. & D. Rubin. 1952. Mephenesin in the treatment of spasticity in multiple sclerosis. J. Nervous Mental Disease. 116: 198 – 209.en_US
dc.identifier.citedreferenceLiddell, E. G. T. 1934. Spinal shock and some features in isolation-alteration of the spinal cord in cats. Brain. 57: 386 – 400.en_US
dc.identifier.citedreferenceLindsley, D. B. 1952. Brain stem influences on spinal motor activity. Research Nervous Mental Disease Proc. 30: 174 – 195.en_US
dc.identifier.citedreferenceLindsley, D. B., L. H. Schreiner & H. W. Magoun. 1949. An electromyographic study of spasticity. J. Neurophysiol. 12: 197 – 205.en_US
dc.identifier.citedreferenceLloyd, D. P. C. 1941a. Activity in neurons of the bulbospinal correlation system. J. Neurophysiol. 4: 115 – 134.en_US
dc.identifier.citedreferenceLloyd, D. P. C. 1941b. The spinal mechanism of the pyramidal system in cats. J. Neurophysiol. 4: 525 – 546.en_US
dc.identifier.citedreferenceLloyd, D. P. C. 1944. Functional organization of the spinal cord. Physiol. Rev. 24: 1 – 17.en_US
dc.identifier.citedreferenceLongo, V. G. 1952. ProprietÀ farmacologiche della diidrobenzo(1–4)Tiazina-azione de-pressiva sulla conduzione interneuronica a livello del sistema nervoso centrale. Arch. Intern. pharmacodynamie. 89: 55 – 64.en_US
dc.identifier.citedreferenceLott, W. A. 1948. Historical introduction, with some general comments concerning the relation between chemical structure and relaxant activity. Symposium on skeletal muscle relaxants. N. Y. Acad. Sci. Series II. 11: 2 – 5.en_US
dc.identifier.citedreferenceMagoun, H. W. & R. Rhines. 1946. An inhibitory mechanism in the bulbar reticular formation. J. Neurophysiol. 9: 165 – 171.en_US
dc.identifier.citedreferenceMagoun, H. W. & R. Rhines. 1947. Spasticity, The Stretch-Reflex and Extrapyramidal Systems. C. C Thomas. Springfield, Ill.en_US
dc.identifier.citedreferenceMantegazza, P., R. Tommasini, R. Fusco & Rossi. 1953. Pharmacological properties of 1-2-4-triazine derivatives: Action on the central nervous system. Arch. Intern. pharmacodynamie. 95: 123 – 152.en_US
dc.identifier.citedreferenceMarsh, D. F. 1955. Comparative pharmacological activity of 2-amino-5-chlorobenzoxazole (McN-485) and other mephenesin-like agents. Federation Proc. 14: 366 – 367.en_US
dc.identifier.citedreferenceMead, S. 1951. Physical treatment in internal medicine. Southern Med. J. 44: 881 – 886.en_US
dc.identifier.citedreferenceMegirian, D. 1953–1954. A neuropharmacological study of beta-erythroidine and its derivatives. Ph.D. thesis. Univ. of Rochester, New York.en_US
dc.identifier.citedreferenceMerlis, J. K. & H. Lawson. 1939. The effect of eserine on spinal reflexes in the dog. J. Neurophysiol. 2: 566 – 572.en_US
dc.identifier.citedreferenceMettler, F. A. 1944. Physiologic effects of bilateral simultaneous frontal lesions in the primate. J. Comp. Neurol. 81: 105 – 136.en_US
dc.identifier.citedreferenceMeyers, R., J. R. Knott, F. M. Skultety & R. Imler. 1954. On the question as to the existence of a “4s” suppressor mechanism. J. Neurosurg. 11: 7 – 23.en_US
dc.identifier.citedreferenceNiemer, W. T. & H. W. Magoun. 1947. Reticulo-spinal tracts influencing motor activity. J. Comp. Neurol. 87: 367 – 379.en_US
dc.identifier.citedreferenceO'leary, J. F., D. E. Leary & I. H. Slater. 1951. Central nervous system activity of some 2-pyridyl compounds. Proc. Soc. Exptl. Biol. Med. 76: 738 – 741.en_US
dc.identifier.citedreferenceOrloff, M. J., H. L. Williams & C. C. Pfeiffer. 1949. Timed intravenous infusion of Metrazol and strychnine for testing anticonvulsant drugs. Proc. Soc. Exptl. Biol. Med. 70: 254 – 257.en_US
dc.identifier.citedreferencePeacock, S. M., Jr. & R. Hodes. 1951. Influence of the forebrain on somatomotor activity. II. Facilitation. J. Comp. Neurol. 94: 409 – 426.en_US
dc.identifier.citedreferencePetersÈn, I. 1952. Differences in sensitivity to anaesthetics of motor centres in the cervical and lumbar region of the spinal cord. Acta Physiol. Scand. Suppl. 96: 1 – 50.en_US
dc.identifier.citedreferencePetersen, R. 1952. Anticonvulsant spectrum of benzothiazoles. Master's thesis. Dept. Pharmacol. Univ. Ill. Chicago, Ill.en_US
dc.identifier.citedreferencePeterson, C. G. 1955. Neuropharmacology of procaine. II. Central nervous action. Anesthesiology. 16: 976 – 993.en_US
dc.identifier.citedreferencePollock, L. J. & L. Davis. 1930. The reflex activities of a decerebrate animal. J. Comp. Neurol. 50: 377 – 411.en_US
dc.identifier.citedreferencePollock, L. J. & Ldavis. 1931. Studies in decerebration. VI. The effect of deafferentation upon decerebrate rigidity. Am. J. Physiol. 98: 47 – 49.en_US
dc.identifier.citedreferenceRenshaw, B. 1940. Activity in the simplest spinal reflex pathways. J. Neurophysiol. 3: 373 – 387.en_US
dc.identifier.citedreferenceSauvage, G. L., F. M. Berger & V. Boekelheide. 1949. Conversion of Β-erythroidine to derivatives of the desmethoxy series and some pharmacological properties of apo-Β-erythroidine. Science. 109: 627 – 628.en_US
dc.identifier.citedreferenceSchÄfer, E. A. 1882. Report on the lesions, primary and secondary, in the brain and spinal cord of the macaque monkey exhibited by Professors Ferrier and Yeo. J. Physiol. 4: 316 – 326.en_US
dc.identifier.citedreferenceSchÄfer, E. A. 1899a. Some results of partial transverse section of the spinal cord. J. Physiol. 24: xxii – xxiv.en_US
dc.identifier.citedreferenceSchÄfer, E. A. 1899b. On the destination of the descending antero-lateral tract in the spinal cord. J. Physiol. 24: xxxii.en_US
dc.identifier.citedreferenceSchlan, L. S. & K. R. Unna. 1949. Some effects of Myanesin in psychiatric patients. J. Am. Med. Assoc. 140: 672 – 673.en_US
dc.identifier.citedreferenceSchlesinger, E. B., A. L. Drew & B. Wood. 1948. Clinical studies in the use of Myanesin. Am. J. Med. 4: 365 – 372.en_US
dc.identifier.citedreferenceSchlesinger, E. B. & F. E. Stinchheld. 1951. The use of muscle relaxants as an aid in the diagnosis and therapy of acute low-back disorders. J. Bone & Joint Surg. 33A: 480 – 484, 501, 504.en_US
dc.identifier.citedreferenceSchneider, J. A. & A. E. Earl. 1954. Effect of o-methoxyphenylglycerol ether (Resyl) on spinal reflex arcs. Proc. Soc. Exptl. Biol. Med. 85: 323 – 326.en_US
dc.identifier.citedreferenceSchreiner, L. H., D. B. Lindsley & H. W. Magoun. 1949. Role of brain stem facilitatory systems in maintenance of spasticity. J. Neurophysiol. 12: 207 – 216.en_US
dc.identifier.citedreferenceSelling, L. S. 1955. Clinical study of a new tranquilizing drug. Use of Miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate). J. Am. Med. Assoc. 157: 1594 – 1596.en_US
dc.identifier.citedreferenceSherrington, C. S. 1889. On nerve-tracts degenerating secondarily to lesions of the cortex cerebri. J. Physiol. 10: 429 – 432.en_US
dc.identifier.citedreferenceSherrington, C. S. 1898. Decerebrate rigidity, and reflex coordination of movements. J. Physiol. 22: 319 – 332.en_US
dc.identifier.citedreferenceSlater, I. H., J. F. O'leary & D. E. Leary. 1950. The effect of 2,2-diethyl 1,3-propanediol (a new anticonvulsant) on spinal cord reflexes. J. Pharmacol. Exptl. Therap. 100: 316 – 324.en_US
dc.identifier.citedreferenceSlater, I. H., J. F. O'leary & D. E. Leary. 1951. Some effects of phenyl-Γ-(2-pyridyl)-propyl ketone (EJA II) on the central nervous system. Federation Proc. 10: 370.en_US
dc.identifier.citedreferenceSmith, R. T. 1949. The treatment of some acute rheumatic disorders. M. Clin. N. Amer. 33: 1619 – 1627.en_US
dc.identifier.citedreferenceSmith, R. T. 1953. Quoted by Goodsell et al. 1954.en_US
dc.identifier.citedreferenceSmith, R. T., K. Kron, W. P. Peak & I. F. Hermann. 1956. Zoxazolamine (Flexin) in rheumatic diseases—preliminary report. J. Am. Med. Assoc. 160: 745 – 748.en_US
dc.identifier.citedreferenceSmith, W. K., P. Dodge, C. N. Luttrell & A. Feldmann. 1949. The site of action of some chemical agents in diminishing normal and excessive muscle tension. Science. 110: 96 – 97.en_US
dc.identifier.citedreferenceSnedecor, G. W. 1946. Statistical Methods Applied to Experiments in Agriculture and Biology. The Collegiate Press, Inc. Ames, Iowa.en_US
dc.identifier.citedreferenceSnider, R. S., H. W. Magoun & W. S. McCulloch. 1947. A suppressor cerebellobulbo-reticular pathway from anterior lobe and paramedian lobules. Federation Proc. 6: 207.en_US
dc.identifier.citedreferenceStella, G. 1944a. Sul meccanismo della rigidita da decerebrazione in arti deafferentati. Atti soc. med. chir. Padova. 22: 5 – 16.en_US
dc.identifier.citedreferenceStella, G. 1944b. Influenza del cerveletto sulla rigidita da decerebrazione. Atti soc. med. chir. Padova. 22: 17 – 21.en_US
dc.identifier.citedreferenceStephen, C. R. & J. Chandy. 1947. Clinical and experimental studies with Myanesin (a preliminary report). Can. Med. Assoc. J. 57: 463 – 468.en_US
dc.identifier.citedreferenceSzentÁgothai-schimert, J. 1941. Die Bedeutung des Faserkalibers und der Markschei-dendicke im Zentralnervensystem. Z. Anat. u. Entwicklungsgeschichte. 111: 201 – 223.en_US
dc.identifier.citedreferenceTakagi, H., M. Matsumura, A. Yanai & K. Ogiu. 1955. The effect of analgesics on the spinal reflex activity of the cat. Japan. J. Pharmacol. 4: 176 – 187.en_US
dc.identifier.citedreferenceTamm, I. 1956. Paper presented at the AAAS meetings in Atlanta, Georgia, 1955. Science. 123: 283.en_US
dc.identifier.citedreferenceTorrens, J. A., P. M. Edwards & M. W. W. Wood. 1948. Myanesin in tetanus. J. Lancet. 255: 807 – 809.en_US
dc.identifier.citedreferenceTower, S. S. 1940. Pyramidal lesion in the monkey. Brain. 63: 36 – 90.en_US
dc.identifier.citedreferenceTraverner, D. 1952. The action of alpha-beta-dihydroxy-gamma-(2-methylphenoxy)-propane (Myanesin) on the spinal cord of the cat. Brit. J. Pharmacol. 7: 655 – 664.en_US
dc.identifier.citedreferenceTureen, L. L. 1936. Effect of experimental temporary vascular occlusion on the spinal cord. I. Correlation between structural and functional changes. Am. Med. Assoc. Arch. Neurol. & Psychiat. 35: 789 – 807.en_US
dc.identifier.citedreferenceUnna, K. R. & A. Kaplan. 1949. Anticonvulsive properties of Myanesin. Federation Proc. 8: 341.en_US
dc.identifier.citedreferenceWagley, P. F. 1945. A study of spasticity and paralysis. Bull. Johns Hopkins Hosp. 77: 218 – 273.en_US
dc.identifier.citedreferenceWalker, H. A., A. P. Richardson, P. Loeb & J. Perog. 1948. The paralytic and lethal action of Myanesin, pentobarbital and combinations of these agents in mice. Federation Proc. 7: 262.en_US
dc.identifier.citedreferenceWelch, W. K. & M. A. Kennard. 1944. Relation of cerebral cortex to spasticity and flaccidity. J. Neurophysiol. 7: 255 – 268.en_US
dc.identifier.citedreferenceWikler, A. 1945. Effects of morphine, Nembutal, ether, and eserine on two-neuron and multineuron reflexes in the cat. Proc. Soc. Exptl. Biol. Med. 58: 193 – 196.en_US
dc.identifier.citedreferenceWikler, A. 1950. Sites and mechanisms of action of morphine and related drugs in the central nervous system. Pharmacol. Rev. 2: 435 – 506.en_US
dc.identifier.citedreferenceWolf, S. & R. H. Pinsky. 1954. Effects of placebo administration and occurrence of toxic reactions. J. Am. Med. Assoc. 155: 339 – 341.en_US
dc.identifier.citedreferenceWoolley, D. W. 1944. Some biological effects produced by benzimidazole and their reversal by purines. J. Biol. Chem. 152: 225 – 232.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1749-6632.1956.tb36842.x.pdf
Size:
1.549MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.